ORGO Q2 2018 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$942,527

Operating Income

-$942,527

Net Income

$356,988

EPS (Diluted)

$-0.30

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$210,082

Free Cash Flow

-$210,082

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$315M

Total Liabilities

$17M

Stockholders' Equity

$298M

Cash & Equivalents

$64,411

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$942,527	-$221,808	-324.9%
Operating Income	-$942,527	-$221,808	-324.9%
Net Income	$356,988	$380,334	-6.1%